Korsana Biosciences, Inc. (KRSA)

NASDAQ: KRSA · Real-Time Price · USD

31.43

-0.57 (-1.78%)

Oct 1, 2026, 2:53 PM EDT - Market open

Korsana Biosciences Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-51.91	-37.29	-0.65
Net Income	-49.08	-35.64	-0.53
Earnings Per Share	-13.37	-12.20	-0.35
EPS Growth	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Cash (Debt)	133.07	154.14	10.11
Net Cash Growth	-	1424.88%	-
Net Cash Per Share	36.25	52.78	6.70
Cash & Investments	133.07	154.14	10.11

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-41.84	-22.41	0.26
Free Cash Flow	-41.84	-22.41	0.26
Free Cash Flow Growth	-	-	-

Valuation

Selected indicators aren't available for this stock.